InsidersTradesSigma
Follow the IRONWOOD PHARMACEUTICALS, INC. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €700.6m. The latest transaction was filed on 7 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: RONALD SILVER. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IRONWOOD PHARMACEUTICALS, INC. is a biopharmaceutical company focused on developing treatments for gastrointestinal disorders. The company is listed on NASDAQ under the ticker symbol IRWD.